Cargando…
PCSK9 is minimally associated with HDL but impairs the anti-atherosclerotic HDL effects on endothelial cell activation
Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) regulates the cell-surface localization of LDL receptors in hepatocytes and is associated with LDL and lipoprotein(a) [Lp(a)] uptake, reducing blood concentrations. However, the connection between PCSK9 and HDL is unclear. Here, we investigated t...
Autores principales: | Dafnis, Ioannis, Tsouka, Aikaterini N., Gkolfinopoulou, Christina, Tellis, Constantinos C., Chroni, Angeliki, Tselepis, Alexandros D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526147/ https://www.ncbi.nlm.nih.gov/pubmed/36067830 http://dx.doi.org/10.1016/j.jlr.2022.100272 |
Ejemplares similares
-
Association between PCSK9 Levels and Markers of Inflammation, Oxidative Stress, and Endothelial Dysfunction in a Population of Nondialysis Chronic Kidney Disease Patients
por: Dounousi, Evangelia, et al.
Publicado: (2021) -
PCSK9 Activity Is Potentiated Through HDL Binding
por: Burnap, Sean A., et al.
Publicado: (2021) -
Effects of increased body weight and short-term weight loss on serum PCSK9 levels – a prospective pilot study
por: Filippatos, Theodosios D, et al.
Publicado: (2017) -
Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux
por: Daniil, Georgios, et al.
Publicado: (2013) -
HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role
por: Casula, Manuela, et al.
Publicado: (2021)